Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Aug;33(8):1126–1128. doi: 10.1136/gut.33.8.1126

Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.

A R Exley 1, T Leese 1, M P Holliday 1, R A Swann 1, J Cohen 1
PMCID: PMC1379456  PMID: 1398241

Abstract

Endotoxaemia and circulating tumour necrosis factor are important prognostic factors in severe sepsis and are implicated in the pathogenesis of septic shock. Because clinical and pathological features in acute pancreatitis are similar to septic shock this study sought to determine whether endotoxin and tumour necrosis factor were prognostic factors in 38 patients with prognostically severe acute pancreatitis. Endotoxaemia, present in 19/37 (51%) patients on day 1, was more common in nonsurvivors than survivors (10/11, 91% v 9/26, 35%, p = 0.003). Day 1 serum endotoxin concentrations were higher in patients with a severe outcome (median (interquartile range) 314 (173-563) pg/ml v 0 (0-185) pg/ml, p<0.01) and in non-survivors (266 (173-586) pg/ml v 0 (0-165) pg/ml, p<0.01). Serum tumour necrosis factor was detectable in 47 of 109 samples (43%) from 38 patients (median 35 pg/ml, range 5-943 pg/ml). Day 1 serum tumour necrosis factor correlated with a worse prognostic score and a severe outcome in all patients (n = 38, r = 0.36, p = 0.027; r = 0.33, p<0.05) and with mortality in patients with gall stones (n = 23, r = 0.50, p = 0.02). Our data suggest that endotoxin and tumour necrosis factor could be prognostic factors in severe acute pancreatitis.

Full text

PDF
1126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balthazar E. J., Robinson D. L., Megibow A. J., Ranson J. H. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990 Feb;174(2):331–336. doi: 10.1148/radiology.174.2.2296641. [DOI] [PubMed] [Google Scholar]
  2. Bayston K. F., Cohen J. Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol. 1990 Feb;31(2):73–83. doi: 10.1099/00222615-31-2-73. [DOI] [PubMed] [Google Scholar]
  3. Beger H. G., Bittner R., Block S., Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986 Aug;91(2):433–438. doi: 10.1016/0016-5085(86)90579-2. [DOI] [PubMed] [Google Scholar]
  4. Bird N. C., Goodman A. J., Johnson A. G. Serum phospholipase A2 activity in acute pancreatitis: an early guide to severity. Br J Surg. 1989 Jul;76(7):731–732. doi: 10.1002/bjs.1800760728. [DOI] [PubMed] [Google Scholar]
  5. Block S., Büchler M., Bittner R., Beger H. G. Sepsis indicators in acute pancreatitis. Pancreas. 1987;2(5):499–505. doi: 10.1097/00006676-198709000-00002. [DOI] [PubMed] [Google Scholar]
  6. Cannon J. G., Tompkins R. G., Gelfand J. A., Michie H. R., Stanford G. G., van der Meer J. W., Endres S., Lonnemann G., Corsetti J., Chernow B. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990 Jan;161(1):79–84. doi: 10.1093/infdis/161.1.79. [DOI] [PubMed] [Google Scholar]
  7. Cohen J., McConnell J. S. Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J Infect Dis. 1984 Dec;150(6):916–924. doi: 10.1093/infdis/150.6.916. [DOI] [PubMed] [Google Scholar]
  8. Debets J. M., Kampmeijer R., van der Linden M. P., Buurman W. A., van der Linden C. J. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med. 1989 Jun;17(6):489–494. doi: 10.1097/00003246-198906000-00001. [DOI] [PubMed] [Google Scholar]
  9. Exley A. R., Cohen J. Optimal collection of blood samples for the measurement of tumor necrosis factor alpha. Cytokine. 1990 Sep;2(5):353–356. doi: 10.1016/1043-4666(90)90065-2. [DOI] [PubMed] [Google Scholar]
  10. Foulis A. K., Murray W. R., Galloway D., McCartney A. C., Lang E., Veitch J., Whaley K. Endotoxaemia and complement activation in acute pancreatitis in man. Gut. 1982 Aug;23(8):656–661. doi: 10.1136/gut.23.8.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Függer R., Hamilton G., Rogy M., Herbst F., Kwasny W., Schemper M., Schultz F. Prognostic significance of endotoxin determination in patients with severe intraabdominal infection. J Infect Dis. 1990 Jun;161(6):1314–1315. doi: 10.1093/infdis/161.6.1314. [DOI] [PubMed] [Google Scholar]
  12. Gross V., Schölmerich J., Leser H. G., Salm R., Lausen M., Rückauer K., Schöffel U., Lay L., Heinisch A., Farthmann E. H. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci. 1990 Jan;35(1):97–105. doi: 10.1007/BF01537230. [DOI] [PubMed] [Google Scholar]
  13. Larvin M., McMahon M. J. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989 Jul 22;2(8656):201–205. doi: 10.1016/s0140-6736(89)90381-4. [DOI] [PubMed] [Google Scholar]
  14. Leese T., Shaw D. Comparison of three Glasgow multifactor prognostic scoring systems in acute pancreatitis. Br J Surg. 1988 May;75(5):460–462. doi: 10.1002/bjs.1800750519. [DOI] [PubMed] [Google Scholar]
  15. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990 Dec 6;348(6301):550–552. doi: 10.1038/348550a0. [DOI] [PubMed] [Google Scholar]
  16. Ranson J. H., Berman R. S. Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis. Ann Surg. 1990 Jun;211(6):708–718. doi: 10.1097/00000658-199006000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Renner I. G., Savage W. T., 3rd, Pantoja J. L., Renner V. J. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci. 1985 Oct;30(10):1005–1018. doi: 10.1007/BF01308298. [DOI] [PubMed] [Google Scholar]
  18. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol. 1988 Mar;3(2-3):105–112. doi: 10.1007/BF02798921. [DOI] [PubMed] [Google Scholar]
  19. Rothstein J. L., Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci U S A. 1988 Jan;85(2):607–611. doi: 10.1073/pnas.85.2.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Silva A. T., Appelmelk B. J., Buurman W. A., Bayston K. F., Cohen J. Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6. J Infect Dis. 1990 Aug;162(2):454–459. doi: 10.1093/infdis/162.2.454. [DOI] [PubMed] [Google Scholar]
  21. Silva A. T., Bayston K. F., Cohen J. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis. 1990 Aug;162(2):421–427. doi: 10.1093/infdis/162.2.421. [DOI] [PubMed] [Google Scholar]
  22. Tracey K. J., Vlassara H., Cerami A. Cachectin/tumour necrosis factor. Lancet. 1989 May 20;1(8647):1122–1126. doi: 10.1016/s0140-6736(89)92394-5. [DOI] [PubMed] [Google Scholar]
  23. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. van Deventer S. J., ten Cate J. W., Tytgat G. N. Intestinal endotoxemia. Clinical significance. Gastroenterology. 1988 Mar;94(3):825–831. doi: 10.1016/0016-5085(88)90261-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES